Is circulating LL-37 a biomarker for eczema severity in children?
Circulating LL-37 may be a biomarker for severity of childhood eczema, which supports the importance of innate immunity in eczema pathogenesis.
Codon 129 polymorphism is not a risk factor for AD in Brazilian patients.